N-Hydroxy-N-methyl-4-benzyloxyphenylacetamide

RG 6866 is a 5-lipoxygenase (5-LOX) inhibitor with the potential to inhibit coronary artery constriction and negative cardiac inotropic effects in cardiac inflammatory states. When the heart is stimulated by antigens, RG 6866 can block the antigen-induced reduction in coronary flow in the heart.

[1] Effects of 5-Lipoxygenase Inhibition on Cardiac Anaphylaxis in Isolated Guinea Pig Hearts